In accordance with the University’s most recent guidance related to COVID-19 we are altering the schedule of upcoming PhD Plus programs and events.  See more about PhDPlus events >> 

PhD+ Commercialization: Funding Landscape - Grant makers, investors, and more

February 11, 2020 | 5:00 pm
Offices of the Licensing and Ventures Group (722 Preston Avenue, Suite 107)

Bob Creeden, Managing Director of the Seed Fund and New Ventures for the UVA Licensing and Venture Group, will lead a discussion of the funding landscape for the commercialization of science.


David TouveSenior Director, Ventures, Batten Institute for Entrepreneurship & Innovation


Kennedy, J. (2012). The sources and uses of U.S. science funding. The New Atlantis, Summer 2012, pp. 3-22.

Link -

Boroush, M. (2016). U.S. R&D Increased by More Than$20 Billion in Both 2013 and 2014, withSimilar Increase Estimated for 2015. National Center for Science and Engineering Statistics, p. 1-9.

Link -

Zider, B. (1998). How venture capital works. Harvard business review76(6), 131-139.

Register here